Fish Oil and Vascular Disease available in Hardcover
- Pub. Date:
- Springer London
Fish Oil and Vascular Disease covers the most relevant aspects of fish oil (n-3 polyunsaturated fatty acids) on vascular disease. The text includes background epidemiological information, nutritional aspects, effects on various biological functions, possibly mediating the effects on atherosclerosis and its clinical sequelae, and offers an extensive coverage of the effects upon blood pressure. The book is divided into three main sections. The first deals with the epidemiological and nutritional background of the n-3 PUFA and their relation to cardiovascular disease.
Table of ContentsEpidemiology and nutrition.- 1. n-3 Fatty Acids: Epidemiological Background and General Introduction.- 2. Dietary Fish Intake and Cardiovascular Protection in Western Populations The Diet and Reinfarction Trial.- 3. Modern Agriculture and Aquaculture and the n-6/n-3 Balance.- 4. Fish Consumption and Blood Pressure: Epidemiological Data.- 5. The Effect of n-3 Fatty Acids on Cardiovascular Risk Factors: An Overview.- 6. n-3 Fatty Acids: Incorporation into Tissue Lipids and Interactions with Dietary Components.- n-3 Fatty Acids and the Vessel Wall.- 7. n-3 Fatty Acids and Platelet-Vessel Wall Interactions.- 8. Platelets, Leukocytes and Atherosclerosis: Possible Links Between n-3 Fatty Acids and Protection from Atherosclerosis.- 9. Cytokines and their Modulation by n-3 Fatty Acids with Regard to Atherogenesis.- 10. The Effect of n-3 Fatty Acids on Blood Coagulation.- 11. n-3 Fatty Acids and Fibrinolysis.- 12. Effects of n-3 Fatty Acids on Monocyte Functions.- 13. Prevention of Cardiac Arrhythmias by n-3 Fatty Acids.- n-3 Fatty Acids and Hypertension.- 14. Essential Hypertension: Current Needs and Methodological Problems with Non-Pharmacological Treatment.- 15. Eicosanoid Dependent and Independent Effects of n-3 Fatty Acids on Platelets and Vascular Function.- 16. n-3 Fatty Acids in Hypertension.- 17. n-3 Fatty Acids in Comparison and in Combination with Other Drugs in the Management of Mild Hypertension.